570 related articles for article (PubMed ID: 25015205)
1. Lung volume reduction after stereotactic ablative radiation therapy of lung tumors: potential application to emphysema.
Binkley MS; Shrager JB; Leung AN; Popat R; Trakul N; Atwood TF; Chaudhuri A; Maxim PG; Diehn M; Loo BW
Int J Radiat Oncol Biol Phys; 2014 Sep; 90(1):216-23. PubMed ID: 25015205
[TBL] [Abstract][Full Text] [Related]
2. Time course and predictive factors for lung volume reduction following stereotactic ablative radiotherapy (SABR) of lung tumors.
Binkley MS; Shrager JB; Chaudhuri A; Popat R; Maxim PG; Shultz DB; Diehn M; Loo BW
Radiat Oncol; 2016 Mar; 11():40. PubMed ID: 26975700
[TBL] [Abstract][Full Text] [Related]
3. Tumor volume-adapted dosing in stereotactic ablative radiotherapy of lung tumors.
Trakul N; Chang CN; Harris J; Chapman C; Rao A; Shen J; Quinlan-Davidson S; Filion EJ; Wakelee HA; Colevas AD; Whyte RI; Dieterich S; Maxim PG; Hristov D; Tran P; Le QT; Loo BW; Diehn M
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):231-7. PubMed ID: 22381907
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancer.
Lagerwaard FJ; Verstegen NE; Haasbeek CJ; Slotman BJ; Paul MA; Smit EF; Senan S
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):348-53. PubMed ID: 22104360
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary function after lung tumor stereotactic ablative radiotherapy depends on regional ventilation within irradiated lung.
Binkley MS; King MT; Shrager JB; Bush K; Chaudhuri AA; Popat R; Gensheimer MF; Maxim PG; Henry Guo H; Diehn M; Nair VS; Loo BW
Radiother Oncol; 2017 May; 123(2):270-275. PubMed ID: 28460826
[TBL] [Abstract][Full Text] [Related]
6. Is there a role for therapeutic lobectomy for emphysema?
Vaughan P; Oey I; Nakas A; Martin-Ucar A; Edwards J; Waller D
Eur J Cardiothorac Surg; 2007 Mar; 31(3):486-90; discussion 490. PubMed ID: 17223565
[TBL] [Abstract][Full Text] [Related]
7. Correlation of computed tomography densitometry and pathological grading of emphysema with the variation of respiratory function after lobectomy for lung cancer.
Carretta A; Ciriaco P; Melloni G; Ballarin A; Bandiera A; Sestini S; Giovanardi M; Zannini P
Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):914-7; discussion 917-8. PubMed ID: 20308264
[TBL] [Abstract][Full Text] [Related]
8. Preoperative severity of emphysema predictive of improvement after lung volume reduction surgery: use of CT morphometry.
Rogers RM; Coxson HO; Sciurba FC; Keenan RJ; Whittall KP; Hogg JC
Chest; 2000 Nov; 118(5):1240-7. PubMed ID: 11083670
[TBL] [Abstract][Full Text] [Related]
9. Planning Target Volume D95 and Mean Dose Should Be Considered for Optimal Local Control for Stereotactic Ablative Radiation Therapy.
Zhao L; Zhou S; Balter P; Shen C; Gomez DR; Welsh JD; Lin SH; Chang JY
Int J Radiat Oncol Biol Phys; 2016 Jul; 95(4):1226-35. PubMed ID: 27209498
[TBL] [Abstract][Full Text] [Related]
10. Short report: interim safety results for a phase II trial measuring the integration of stereotactic ablative radiotherapy (SABR) plus surgery for early stage non-small cell lung cancer (MISSILE-NSCLC).
Palma DA; Nguyen TK; Kwan K; Gaede S; Landis M; Malthaner R; Fortin D; Louie AV; Frechette E; Rodrigues GB; Yaremko B; Yu E; Dar AR; Lee TY; Gratton A; Warner A; Ward A; Inculet R
Radiat Oncol; 2017 Jan; 12(1):30. PubMed ID: 28129789
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary function and quality of life after VMAT-based stereotactic ablative radiotherapy for early stage inoperable NSCLC: a prospective study.
Ferrero C; Badellino S; Filippi AR; Focaraccio L; Giaj Levra M; Levis M; Moretto F; Torchio R; Ricardi U; Novello S
Lung Cancer; 2015 Sep; 89(3):350-6. PubMed ID: 26164208
[TBL] [Abstract][Full Text] [Related]
12. Distinguishing radiation fibrosis from tumour recurrence after stereotactic ablative radiotherapy (SABR) for lung cancer: a quantitative analysis of CT density changes.
Mattonen SA; Palma DA; Haasbeek CJ; Senan S; Ward AD
Acta Oncol; 2013 Jun; 52(5):910-8. PubMed ID: 23106174
[TBL] [Abstract][Full Text] [Related]
13. Lack of a dose-effect relationship for pulmonary function changes after stereotactic body radiation therapy for early-stage non-small cell lung cancer.
Guckenberger M; Klement RJ; Kestin LL; Hope AJ; Belderbos J; Werner-Wasik M; Yan D; Sonke JJ; Bissonnette JP; Xiao Y; Grills IS
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(4):1074-81. PubMed ID: 23154077
[TBL] [Abstract][Full Text] [Related]
14. Study of 201 non-small cell lung cancer patients given stereotactic ablative radiation therapy shows local control dependence on dose calculation algorithm.
Latifi K; Oliver J; Baker R; Dilling TJ; Stevens CW; Kim J; Yue B; Demarco M; Zhang GG; Moros EG; Feygelman V
Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1108-13. PubMed ID: 24529716
[TBL] [Abstract][Full Text] [Related]
15. Residual ¹⁸F-FDG-PET uptake 12 weeks after stereotactic ablative radiotherapy for stage I non-small-cell lung cancer predicts local control.
Bollineni VR; Widder J; Pruim J; Langendijk JA; Wiegman EM
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):e551-5. PubMed ID: 22417800
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of stereotactic ablative radiotherapy for centrally located early-stage lung cancer.
Haasbeek CJ; Lagerwaard FJ; Slotman BJ; Senan S
J Thorac Oncol; 2011 Dec; 6(12):2036-43. PubMed ID: 21892102
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic Ablative Radiation Therapy for the Treatment of Early-stage Non-Small-Cell Lung Cancer: CEPO Review and Recommendations.
Boily G; Filion É; Rakovich G; Kopek N; Tremblay L; Samson B; Goulet S; Roy I;
J Thorac Oncol; 2015 Jun; 10(6):872-82. PubMed ID: 26001140
[TBL] [Abstract][Full Text] [Related]
18. Computed tomography with volume rendering for the evaluation of parenchymal hyperinflation after bronchoscopic lung volume reduction.
D'Andrilli A; Vismara L; Rolla M; Ibrahim M; Venuta F; Pochesci I; Masciangelo R; Rendina EA
Eur J Cardiothorac Surg; 2009 Mar; 35(3):403-7. PubMed ID: 19084426
[TBL] [Abstract][Full Text] [Related]
19. Assessment of volume reduction effect after lung lobectomy for cancer.
Ueda K; Murakami J; Sano F; Hayashi M; Kobayashi T; Kunihiro Y; Hamano K
J Surg Res; 2015 Jul; 197(1):176-82. PubMed ID: 25891678
[TBL] [Abstract][Full Text] [Related]
20. Repeated lung volume reduction surgery is successful in selected patients.
Kostron A; Horn-Tutic M; Franzen D; Kestenholz P; Schneiter D; Opitz I; Kohler M; Weder W
Eur J Cardiothorac Surg; 2015 Nov; 48(5):710-5. PubMed ID: 25548131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
